FACTORS IN THE DESIGN OF ACTIVE-SITE-DIRECTED IRREVERSIBLE INHIBITORS.
D000963:Antimetabolites; D002626:Chemistry, Pharmaceutical; D002918:Chymotrypsin; D004791:Enzyme Inhibitors; D005969:Glutamate Dehydrogenase; D007531:Isoflurophate; D007770:L-Lactate Dehydrogenase; D010604:Pharmacy
D000963:Antimetabolites; D004791:Enzyme Inhibitors; D007531:Isoflurophate; D007770:L-Lactate Dehydrogenase; D005969:Glutamate Dehydrogenase; D002918:Chymotrypsin
ANTIMETABOLITES; CHEMISTRY, PHARMACEUTICAL; CHYMOTRYPSIN; ENZYME INHIBITORS; GLUTAMATE DEHYDROGENASE; ISOFLUROPHATE; LACTATE DEHYDROGENASE; REVIEW